Home > Publications > Articles > praAmicus Curiae Efforts to Reform Product Liability at the Food and Drug Administration: FDA’s Influence on Federal Preemption of Class III Medical Devices and Pharmaceuticals

praAmicus Curiae Efforts to Reform Product Liability at the Food and Drug Administration: FDA’s Influence on Federal Preemption of Class III Medical Devices and Pharmaceuticals

Posted:
12/01/2005
Services:
Corporate
Industries:
Life Sciences

In this article, Gregory J. Wartman, an Associate in the Litigation Department, discusses the use of amicus curiae briefs in relation to the Food and Drug Administration.

With permission from FDLI, to read the article, click the link below.